| Makale Türü | Özgün Makale (SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale) | ||
| Dergi Adı | FUTURE MEDICINAL CHEMISTRY (Q3) | ||
| Dergi ISSN | 1756-8919 Dergi Bilgileri (2026) | ||
| Dergi Tarandığı Indeksler | SCI-Expanded | ||
| Makale Dili | Türkçe | Basım Tarihi | 02-2026 |
| Cilt / Sayı / Sayfa | 18 / 3 / 237–253 | DOI | 10.1080/17568919.2026.2617608 |
| Makale Linki | https://doi.org/10.1080/17568919.2026.2617608 | ||
| UAK Araştırma Alanları |
Tıbbi Biyokimya
|
||
| Özet |
| AimsTo develop isovanillin-based bis-hydrazones as multitarget inhibitors of acetylcholinesterase (AChE), butyrylcholinesterase (BChE), and human carbonic anhydrase I/II (hCA I/II).Materials & methodsTwelve bis-hydrazones (4a–4l) were synthesized in two steps and evaluated by spectrophotometric enzyme assays, Lineweaver–Burk kinetics, molecular docking, MM-GBSA, molecular dynamics simulations, and in silico ADME/Tox profiling.ResultsAll compounds showed nanomolar inhibition. Compound 4d was the most potent AChE/BChE inhibitor (KI = 10.46 and 3.56 nM), while 4a and 4j led the hCA I/II panel (KI = 3.46 and 16.12 nM). Docking, MM-GBSA, and molecular dynamics supported dual-site cholinesterase engagement and non-zinc, peripherally anchored hCA inhibition.ConclusionsIsovanillin-based bis-hydrazones, particularly 4d, 4a, and 4j, represent promising multitarget leads for cholinergic and h … |
| Anahtar Kelimeler |
| Isovanillin | bis-hydrazone derivatives | cholinesterase inhibition | carbonic anhydrase inhibition | molecular docking | ADMET profiling | molecular dynamics |
| Atıf Sayıları | |
| Web of Science | 10 |
| Google Scholar | 12 |
| Dergi Adı | Future Medicinal Chemistry |
| Kısa Adı | FUTURE MED CHEM |
| Yayıncı | TAYLOR & FRANCIS LTD |
| Açık Erişim | Hayır |
| ISSN | 1756-8919 |
| E-ISSN | 1756-8927 |
| Wos Quartile | Q3 |
| Scopus Quartile | Q3 |
| Tarandığı Indeksler | SCIE , Scopus |
| WoS Kategoriler | CHEMISTRY, MEDICINAL |
| Scopus Kategoriler | DRUG DISCOVERY | PHARMACOLOGY | MOLECULAR MEDICINE |